PitchSend

Popular
Blog
Companies
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Healthy Growth across all verticals in FY'22 slide image

Healthy Growth across all verticals in FY'22

Innovation is driving growth- New product development is our core competency BETA Brugs DRUGS LTD. Expertise in NDDS (New Drug Delivery System) Proven experience in managing complex product development- Azacitidine Oral, Ready to Use Gemcitabine & Docetaxel R&D expenditure (Value in Crs) 1.3 2.5 Working on FTLs- 1st product to be launched in Q2 FY'22 FY'21 FY'22 Pipeline of 23 Products which are going to be off-patent in next 5 Years 5
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube